FFA
JAZZ icon

Farther Finance Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Farther Finance Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$636K Buy
2,749
+1,186
+76% +$293K ﹤0.01% 1412
2026
Q2 		$376K Buy
1,563
+990
+173% +$217K ﹤0.01% 1763
2026
Q1 		$108K Sell
573
-84
-13% -$14.7K ﹤0.01% 2457
2025
Q4 		$112K Buy
657
+392
+148% +$60.1K ﹤0.01% 2274
2025
Q3 		$34.9K Buy
265
+234
+755% +$28.1K ﹤0.01% 2670
2025
Q2 		$3.29K Sell
31
-49
-61% -$5.32K ﹤0.01% 3526
2025
Q1 		$10K Sell
80
-40
-33% -$5.22K ﹤0.01% 2734
2024
Q4 		$14.8K Buy
120
+51
+74% +$6.01K ﹤0.01% 2216
2024
Q3 		$7.69K Sell
69
-4
-5% -$438 ﹤0.01% 2469
2024
Q2 		$7.77K Buy
73
+53
+265% +$5.83K ﹤0.01% 2177
2024
Q1 		$2.38K Sell
20
-27
-57% -$3.31K ﹤0.01% 2416
2023
Q4 		$5.78K Buy
47
+10
+27% +$1.25K ﹤0.01% 1891
2023
Q3 		$4.79K Buy
37
+8
+28% +$1.07K ﹤0.01% 1530
2023
Q2 		$3.6K Buy
29
+3
+12% +$404 ﹤0.01% 1549
2023
Q1 		$3.81K Buy
26
+2
+8% +$296 ﹤0.01% 1423
2022
Q4 		$3.82K Buy
+24
New +$3.52K ﹤0.01% 1258

Other funds holding JAZZ

ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.59B AUM 21.04% 1-Year Est. Return

Farther Finance Advisors's JAZZ Position: Q3 2026 in Review

Farther Finance Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 76% in Q3 2026, buying an estimated $293K and bringing the position to 2,749 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

Farther Finance Advisors first reported a position in JAZZ in Q4 2022 and has held it in 16 quarters since. 21 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Farther Finance Advisors held 2,749 shares of Jazz Pharmaceuticals worth $636K as of Q3 2026.
  • Farther Finance Advisors bought 1,186 Jazz Pharmaceuticals shares in Q3 2026, an estimated $293K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1412 holding.
  • Farther Finance Advisors first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • 21 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.